Valvular Heart Disease

Valvular heart disease management is increasingly transcatheter and increasingly personalised. Sessions cover aortic stenosis (TAVR vs SAVR across risk strata, bicuspid anatomy, lifetime management), mitral regurgitation (TEER, transcatheter mitral replacement, surgical repair), tricuspid intervention (TriClip, EVOQUE, replacement), rheumatic and degenerative pathology, infective endocarditis and valve-in-valve. Discussion includes Heart Team decision-making, imaging integration, anticoagulation strategies and durability data from multi-year cohorts.